According to a report from The Globe and Mail on November 14, Canadian anti-smoking advocates are urging the federal government to restrict the sale of the recently approved flavored nicotine product called "Zonnic" by the Ministry of Health. They have issued a warning stating that this product is being marketed and directly sold to children and adolescents.
Imperial Tobacco Canada, a subsidiary of British-American Tobacco, recently launched a nicotine pouch product called "Zonnic" in Canada. Each pouch contains four milligrams of nicotine and is designed to be placed under the user's lip.
However, anti-tobacco advocates are urging the federal government to restrict the sale of this product, or even suspend its sale altogether, in order to prevent underage individuals from purchasing it, given its increasing popularity and young user base in multiple countries, including the United States.
The open sale of Zonnic nicotine pouches in convenience stores and gas stations is causing concern about its impact on minors, despite being positioned by the company as an "adult tobacco alternative.
Anti-smoking groups, including the Canadian Cancer Society and the Canadian Doctors for Tobacco Control, are urging the government to take immediate action by implementing prescription-only sales for nicotine pouches. They are also calling for a suspension of approvals for similar products unless they too are subject to prescription-only sales.
British American Tobacco has identified nicotine pouches, which it refers to as "modern oral," as an important area for growth. During a meeting in September, Kingsley Wheaton, Chief Strategy and Growth Officer at British American Tobacco, expressed excitement about the future development of the company's modern oral products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
